FISCHER NSE filing

Fischer Medical Ventures Files SEBI Certificate for Quarter Ended June 30, 2026

The RealCase readLow impact Neutral

Fischer Medical Ventures Limited has submitted a certificate for the quarter ended June 30, 2026, as per SEBI regulations. The certificate was issued by its Registrar and Share Transfer Agent, confirming the processing of dematerialised securities.

Why it matters

This is a routine regulatory filing that is standard practice for listed companies and does not have a significant impact on the company's operations or financial standing.

The market read

The announcement is a routine compliance filing and does not contain any information that positively or negatively impacts the company's outlook.

Fischer Medical Ventures Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended June 30, 2026.

The certificate was issued by the company's Registrar and Share Transfer Agent, M/s. Adroit Corporate Services Pvt. Ltd. It confirms that securities received from depository participants for dematerialisation during the quarter were processed, and the security certificates were mutilated and cancelled after verification. The depositories' names have been substituted in the register of members as the registered owner within the stipulated 15 days.

The company has requested that this information be taken on record.

Filing to action

What to do with a filing like this

Fischer Medical Ventures Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.

View original filing